Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corporation

World Rank (Aug-2026)
4223
Market Cap (Aug-2026)
3.948 Billion USD
Market Cap (Mar-08-2026)
2.288 Billion USD
World Rank (Jan-05-2024)
10,807
Market Cap (Jan-05-2024)
0.673 Billion USD
World Rank (Jul-30-2023)
7,981
Market Cap (Jul-30-2023)
1.165 Billion USD
World Rank (Jan-07-2022)
4,537
Market Cap (Jan-07-2022)
3.270 Billion USD
World Rank (Jan-01-2021)
1,990
Market Cap (Jan-01-2021)
8.087 Billion USD
Headquarters Country
USA
Top Healthcare Companies in USA
Nasdaq / NYSE Code
ADPT
Employee Count
858
Employee Count as of Date
As on 2021
Headquarters City/State
Washington
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
277 Million USD
Annual Operating Income in USD
-57 Million USD
Annual Net Income in USD
-59 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
513 Million USD
Total Liabilities in USD
288 Million USD
Total Equity in USD
225 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Biotechnology
Medical Equipment / Instruments
Company Website
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Yahoo
Yahoo @ Nasdaq
Company Profile

Adaptive Biotechnologies Corporation is a Life Science Equipment and Technology company. The company products and services of both current and pipeline, supporting life sciences research, clinical diagnostics and drug discovery, aim is to add an entirely new dimension to the diagnosis and treatment of disease from cancer to autoimmune conditions to infectious diseases. The headquarters is in USA.

Annual Results Summary

ADAPTIVE BIOTECHNOLOGIES CORPORATION - Annual Results Summary - in Million USD

Year Ending:Total RevenueOperating IncomeNet Income
Dec-2022185-200 (Loss)-200 (Loss)
Dec-2021154 -208 (Loss)-207 (Loss)
Dec-202098.4(152.8)(146.2)
Dec-201985.1(78.4)(68.6)
Dec-201855.7(49.8)(46.4)
Dec-201738.4(44.5)(42.8)
Balance Sheet Summary

Total Assets as on Dec-2022 was 856 Million USD.

Total Liabilities as on Dec-2022 was 392 Million USD.

Total Equity as on Dec-2022 was 464 Million USD.

Founded Year
2009
IPO Year
2019
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Biological Products (No Diagnostic Substances)

Share